Asset
EPI-589
PTC Therapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02460679 | phase2 | completed | 2016-01-14 | 2018-02-23 | PTC Therapeutics | Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS) |
FDA applications (0)
This company has no applications containing this asset.